Menoza, Felisa S.

HRN: 29-50-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/19/2026
08/26/2026
IV
600MG
Q8
INFECTED WOUND
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: